← Browse by Condition
Medical Condition

urinary tract infections

Total Trials
9
Recruiting Now
9
Trial Phases
Phase 4, Phase 1

ClinicalMetric tracks all active clinical trials for urinary tract infections sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — urinary tract infections Clinical Trials

How many clinical trials are currently recruiting for urinary tract infections?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for urinary tract infections, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for urinary tract infections?
urinary tract infections research spans Phase 1 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a urinary tract infections clinical trial?
Eligibility criteria for urinary tract infections trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 4
2
Top Sponsors
University Medical Center Groningen 1 trial
Centre Hospitalier Intercommunal Creteil 1 trial
Wake Forest University Health Sciences 1 trial
Infectopharm Arzneimittel GmbH 1 trial
The University of Hong Kong 1 trial

Recruiting Clinical Trials

NCT04615065
Recruiting
Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
Enrollment
35,000 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
View Trial →
NCT03825874
Recruiting
Research of the Consequences on the Digestive Tract Following the Proposed Treatments for a Urinary Infection in Children
Enrollment
200 pts
Location
France
Sponsor
Centre Hospitalier Intercommun...
View Trial →
NCT05206500 Phase 4
Recruiting
NextGen - Clinical Implication of Next Generation Sequencing
Enrollment
100 pts
Location
United States
Sponsor
Wake Forest University Health ...
View Trial →
NCT02979951
Recruiting
Fosfomycin I.v. for Treatment of Severely Infected Patients
Enrollment
1,000 pts
Location
Austria, Germany, Gr...
Sponsor
Infectopharm Arzneimittel GmbH
View Trial →
NCT06918769
Recruiting
The Application of a Novel Urinalysis System (UF-5000) for Reducing Unnecessary Antibiotic Use in Clinical Suspected UTI Patients
Enrollment
200 pts
Location
Hong Kong
Sponsor
The University of Hong Kong
View Trial →
NCT06503588
Recruiting
Ureteral Stent Exchange Abstention in Urinary Tract Infections
Enrollment
300 pts
Location
France
Sponsor
Central Hospital, Nancy, Franc...
View Trial →
NCT07207291 Phase 1
Recruiting
Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers
Enrollment
66 pts
Location
China
Sponsor
Joincare Pharmaceutical Group ...
View Trial →
NCT06976125
Recruiting
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
Enrollment
47 pts
Location
United States
Sponsor
University Hospitals Cleveland...
View Trial →
NCT04095572 Phase 4
Recruiting
Alternative Prophylaxis in Female Recurrent Urinary Tract Infections
Enrollment
50 pts
Location
Switzerland
Sponsor
University Hospital, Basel, Sw...
View Trial →

Related Conditions

sepsis (2) bacterial infections (2) respiratory tract infections (2) acute disease (1) pneumonia (1) frailty (1) complication of treatment (1) pulmonary embolism (1) thrombosis (1) acute kidney injury (1) electrolyte disturbance (1) hemorrhage (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology